improv glucose-induc insulin secret diabet rat long-term gliclazid treatment compar studi differ model non-insulin-depend diabet mellitu neonat streptozotocin understand long-term action sulfonylurea human non-insulin-depend diabet niddm effect long-term sulfonylurea administr anim model diseas studi differ version neonat streptozotocin-induc diabet stz model niddm model stz day birth basal hyperglycemia mark reduct pancreat insulin store insulin resist model stz day birth mild hyperglycemia reduct pancreat insulin content insulin resist diabet rat oral gliclazid mg/kg/day untreat diabet rat nondiabet rat insulin secret day last gliclazid isol perfus pancrea prepar sever hyperglycem rat glucos level mmol/l long-term gliclazid treatment plasma glucos valu pancreat insulin store vitro insulin releas respons hyperglycem rat glucos level mmol/l plasma glucos level mean mmol/l end gliclazid therapi increas pancreat insulin store rat margin rat treatment plasma glucos level pancreat insulin store gliclazid therapi gliclazid respond group group vitro glucose-induc insulin secret three- respons diabet rat two- insulin releas respons unchang conclus long-term gliclazid therapi augment insulin secret rat model niddm refractori short-term sulfonylurea administr improv beta-cel function concomit variat hyperglycemia and/or pancreat insulin content 